MICROBIOTA AND BLADDER CANCER

Abroad (travel likely)Recruiting

Conditions

Bladder (Urothelial, Transitional Cell) Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Cannes Hospital, Cannes, France
Contact: Study coordinator (Romain HAIDER) · R.HAIDER@ch-cannes.fr · 04 92 18 37 70
Contact: Principal Investigator (Romain HAIDER)
Marseille university Hospital, Marseille, France
Contact: Study coordinator (Romain BOISSIER) · Romain.Boissier@ap-hm.fr · 04 91 43 51 70
Contact: Principal Investigator (Romain BOISSIER)
Menton Hospital, Menton, France
Contact: Study coordinator (Khaled YOUSSEF) · k.youssef@ch-menton.fr · 04.93.28.72.60
Contact: Principal Investigator (Khaled YOUSSEF)
Nice University Hospital, Nice, France
Contact: Study coordinator (Alice GAUDART) · gaudart.a@chu-nice.fr · 0492036214
Contact: Study coordinator (Romain LOTTE) · lotte.r@chu-nice.fr
Contact: Principal Investigator (Mathieu DURANT)
Nimes University hospital, Nîmes, France
Contact: Study coordinator (Stephane DROUPY) · droupy.s@chu-nimes.fr · 04 92 03 46 72
Contact: Principal Investigator (Stephane DROUPY)
Paris University Hospital, Paris, France
Contact: Study coordinator (Jean françois HERMIEU) · jean-francois.hermieu@bch.aphp.fr · 01 40 25 71 03
Contact: Principal Investigator (Jean François HERMIEU)
Rennes University Hospital, Rennes, France
Contact: Study coordinator (Romain MATHIEU) · romain.MATHIEU@chu-rennes.fr · 02 99 28 42 70
Contact: Principal Investigator (Romain MATHIEU)
Tours University Hospital, Tours, France
Contact: Study coordinator (Ali BOURGI) · ali.bourgi@univ-tours.fr · 02 47 47 39 17

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma

Urothelial Carcinoma (UC) · Bladder (Urothelial, Transitional Cell) Cancer · Liquid Biopsy

Abroad (travel likely)Recruiting

Tianjin, China

Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients

Bladder (Urothelial, Transitional Cell) Cancer

Abroad (travel likely)RecruitingPHASE1

Guangzhou, China

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Bladder (Urothelial, Transitional Cell) Cancer · Non-Muscle Invasive Bladder Carcinoma · Non-muscle Invasive Bladder Cancer With Carcinoma in Situ

Abroad (travel likely)RecruitingPHASE3

Queen Creek, United States · Little Rock, United States

Selecting Hypoxic Tumours for Treatment Modification

Bladder (Urothelial, Transitional Cell) Cancer · Prostate Cancer

Abroad (travel likely)Recruiting

Manchester, United Kingdom